News
The Unified Patent Court (UPC) has quickly become an important forum for pharmaceutical and biotech patent disputes in Europe ...
8h
Zacks Investment Research on MSNLilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...
Served on Celgene's Executive Committee and played a key leadership role in the BMS transaction, the integration of Celgene into BMS, and the divestiture of Otezla® to Amgen Appointment marks a key ...
Q2 2025 Earnings Call Transcript May 12, 2025 Arrowhead Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $2 ...
51m
Barchart on MSNStocks Settle Mixed on Chip Stock Strength and Higher Bond YieldsStock indexes on Wednesday settled mixed, with the Nasdaq 100 posting a 2-1/2 month high. The strength in chip makers Wednesday supported gains in the broader market. The Trump administration is ...
First approved in 2010, RANK ligand (RANKL) inhibitor Prolia remains an important drug for Amgen. The company recorded sales of $3.25 billion for the drug last year, two thirds from the US market.
In recent years, the demand for cars for sale Philippines has increased incredibly. Thanks to its flexibility, many people choose Honda for sale as the primary vehicle in their daily life. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results